Paul Tudor Jones Uni Qure N.V. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Uni Qure N.V. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 23,413 shares of QURE stock, worth $135,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,413
Previous 23,479
0.28%
Holding current value
$135,327
Previous $105,000
9.52%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding QURE
# of Institutions
153Shares Held
41MCall Options Held
925KPut Options Held
617K-
Vestal Point Capital, LP New York, NY4.75MShares$27.5 Million1.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.78MShares$16.1 Million0.81% of portfolio
-
Boxer Capital, LLC San Diego, CA2.23MShares$12.9 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$12.7 Million0.01% of portfolio
-
Abrdn PLC1.93MShares$11.1 Million0.02% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $270M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...